FIELD: biology; medicine.
SUBSTANCE: invention relates to experimental biology and medicine and can be used for optimization of oxygen-dependent processes with prolonged administration of simvastatin to animals. That is ensured by inducing essential hypercholesterolemia in outbred male rats, and then animal once a day for two months receives simvastatin 20 mg and lipoic acid 600 mg in a therapeutic dosage in terms of 100 g of a mass in the form of an aqueous suspension through an esophageal probe.
EFFECT: method enables eliminating side effects associated with depression of energy processes accompanying prolonged simvastatin therapy by reducing the level of lactate and changing the glutathione link enzyme indices, which indicates antioxidant protection reorganization.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ESSENTIAL HYPERCHOLESTEROLAEMIA MODELLING | 2020 |
|
RU2733693C1 |
MEDICINAL AGENT "SIMVAGLISIN" WITH HYPOLIPIDEMIC EFFECT | 2006 |
|
RU2308947C1 |
COMPOSITION FOR NORMALIZATION OF LIPID METABOLISM AND REDUCING BODY MASS AND METHOD FOR ITS PREPARING | 2005 |
|
RU2290185C1 |
ANTI-INFLAMMATORY OINTMENT WITH HYPOLIPIDEMIC EFFECT | 2004 |
|
RU2276973C2 |
METHOD FOR CORRECTION OF CARBOHYDRATE-PROTEIN METABOLIC DISTURBANCE IN PANCREATIC CONNECTIVE TISSUE IN EXPERIMENTAL PRENATAL ALCOHOLIC INTOXICATION | 2011 |
|
RU2472230C2 |
METHOD FOR DESCRIBING INDICATIONS FOR CHOOSING CONSERVATIVE THERAPEUTIC APPROACH TO PATIENTS SUFFERED RECURRENT MYOCARDIAL INFARCTION | 2012 |
|
RU2487353C1 |
METHOD FOR PREVENTION OF RAT'S LIVER, MYOCARDIUM AND PANCREAS INJURY IN CHRONIC ALCOHOLIC INTOXICATION MODELLING | 2009 |
|
RU2422916C1 |
ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
Authors
Dates
2021-01-28—Published
2020-07-17—Filed